Event date
  • Rheumatology
  • 14.00 AMA PRA Category 1 Credit™
  • 14.00 Participation
  • 16.75 AMA PRA Category 1 Credit™
  • 16.75 Nursing Contact Hours
  • 16.75 Participation
THIS IS A HYBRID COURSECurrent treatment strategies for patients with complex digestive disorders continue to evolve.  This is largely the result of growing technological advances in surgery and endoscopy. The goal of the Minimally Invasive and Novel Therapeutics (MINT) course is to inform physicians on how best to incorporate these technologies into their practice. Using a video-based format, our goal is technique transfer from world-renowned faculty to the community, hospital, endoscopy suite, and operating room.
  • Oncology
  • 7.25 AMA PRA Category 1 Credit™
  • 7.25 Nursing Contact Hours
  • 7.25 Participation
Staying abreast of the rapidly advancing field of prostate imaging is paramount to the successful staging and treatment of patients with prostate cancer. This one-day CME course, State of the Art Imaging in the Diagnosis and Management of Prostate Cancer, will discuss current and new developments in multiparametric MRI (mpMRI), MRI-ultrasound fusion biopsy, including transperineal biopsy, PSMA PET imaging, focal therapy treatment options, and other recent advances in imaging technology and diagnostics/therapeutics for prostate cancer.
  • Hematology
  • Oncology
  • 13.50 ABIM MOC II
  • 13.50 AMA PRA Category 1 Credit™
  • 13.50 Nursing Contact Hours
  • 13.50 Participation
Please Note:This course has two components you can register for. You can either register for the symposium only, Immunotherapy Toxicities session only, or both